Meeting to Tackle Drug Development Challenges for Idiopathic Hypersomnia
Summary: The Sleep Consortium announced the Illuminate Hypersomnia Adjunct Scientific Meeting, a virtual session on Feb 13, 2025, to address drug development challenges for idiopathic hypersomnia (IH). Building on insights from a previous patient-focused meeting and survey, the event will bring together experts in sleep medicine, pharmaceutical research, and advocacy to tackle barriers in IH…